gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention relates to methods for producing antibodies.
|
gptkbp:applicationNumber
|
10/2003,123,456
|
gptkbp:applicationPublication
|
gptkb:US_2003/0123456_A1
|
gptkbp:applicationType
|
non-provisional
|
gptkbp:assignee
|
gptkb:Genentech,_Inc.
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:coInventor
|
gptkb:Alice_Johnson
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
March 15, 2022
|
gptkbp:fieldOfInvention
|
biotechnology
|
gptkbp:fieldOfUse
|
therapeutics
|
gptkbp:filingDate
|
March 15, 2002
|
gptkbp:fullText
|
Available online
|
gptkbp:grantDate
|
September 7, 2004
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,029 C28
|
gptkbp:internationalClassification
|
C07K 16/28
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:inventorCountry
|
gptkb:USA
|
gptkbp:issuedOn
|
September 7, 2004
|
gptkbp:legalStatus
|
expired
|
gptkbp:patentAbstract
|
Methods for producing antibodies.
|
gptkbp:patentAssignee
|
gptkb:Genentech,_Inc.
|
gptkbp:patentCitation
|
gptkb:US_5,123,456_A
|
gptkbp:patentClaim
|
20 claims.
|
gptkbp:patentClassification
|
C07K
C07K 16
|
gptkbp:patentDescription
|
Detailed description of the invention.
|
gptkbp:patentExpiration
|
March 15, 2022
|
gptkbp:patentFamily
|
gptkb:US_6,789,029
|
gptkbp:patentFamilyMembers
|
US_6,789,029,_US_7,123,456
|
gptkbp:patentField
|
Biotechnology
|
gptkbp:patentFilingDate
|
March 15, 2002
September 7, 2004
|
gptkbp:patentInventor
|
John_Doe,_Alice_Johnson
|
gptkbp:patentNumber
|
6,789,029
|
gptkbp:patentOffice
|
gptkb:USPTO
|
gptkbp:patentStatus
|
granted
|
gptkbp:patentType
|
utility
Utility patent
|
gptkbp:priorityDate
|
March 15, 2001
|
gptkbp:relatedTo
|
monoclonal antibodies
|
gptkbp:status
|
active
|
gptkbp:subclass
|
C07K 16
|
gptkbp:title
|
Methods for producing antibodies
|